Vir Biotechnology to Participate in the 42nd Annual Cowen Healthcare Conference
March 02, 2022 16:02 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, March 02, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in an infectious disease panel discussion at the 42nd Annual...
Worldwide Monoclonal Antibodies Industry to 2028 - Rising Prevalence of Cancer and Other Chronic Diseases are Driving Growth
February 25, 2022 07:58 ET
|
Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source, Production Method, Indication, Application, and...
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
February 24, 2022 16:04 ET
|
Vir Biotechnology, Inc.
– Significant progress made increasing global patient access to sotrovimab; approximately 1.7 million doses sold to date – – $917.2 million of sotrovimab collaboration revenue recognized in 2021 – –...
Global Multiplex Assays Market Growth Opportunities to 2026: Increasing Validation of Biomarkers in Molecular and Protein Diagnostics
February 23, 2022 04:43 ET
|
Research and Markets
Dublin, Feb. 23, 2022 (GLOBE NEWSWIRE) -- The "Multiplex Assays Market by Product (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry,...
Antibody Therapy Market Revenue to hit $445 Billion by 2028, Says Global Market Insights Inc.
February 22, 2022 03:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Global antibody therapy market value projected to cross USD 445 billion by 2028, according to a new research report by Global Market...
Global Oncology/Cancer Drugs Market (2021 to 2030) - by Drug Class Type, Indication and Region
February 18, 2022 09:03 ET
|
Research and Markets
Dublin, Feb. 18, 2022 (GLOBE NEWSWIRE) -- The "Oncology/Cancer Drugs Market By Drug Class Type, By Indication" report has been added to ResearchAndMarkets.com's offering. The global oncology/cancer...
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
February 10, 2022 16:02 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the fourth quarter...
Global Immunotherapy Market Research Report 2021: Focus on Monoclonal Antibodies, Cancer Vaccines, Autoimmune Checkpoint Inhibitors, & Interleukins and Interferons (Cytokinins)
February 08, 2022 04:13 ET
|
Research and Markets
Dublin, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The "Immunotherapy Market 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global Immunotherapy market is projected to grow at a...
Global Monoclonal Antibodies Market (2020 to 2030) - by Source, Category, Production Type, Application, End User and Region
January 25, 2022 05:43 ET
|
Research and Markets
Dublin, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies Market 2020-2030 by Source, Category, Production Type, Application, End User, and Region: Trend Forecast and Growth...
Worldwide Filgrastim Industry to 2027 - An Increase in the Aging Population is Driving Growth
January 21, 2022 04:29 ET
|
Research and Markets
Dublin, Jan. 21, 2022 (GLOBE NEWSWIRE) -- The "Global Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027"...